Huapont Life Sciences Co.,Ltd. (SHE:002004)
China
· Delayed Price · Currency is CNY 4.090
+0.010 (0.25%)
May 23, 2025, 2:45 PM CST
Huapont Life Sciences Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Jan '21 Jan 1, 2021 | 2015 - 2019 |
| Operating Revenue | 11,413 | 11,508 | 11,409 | 13,021 | 12,290 | 10,732 | Upgrade
|
| Other Revenue | 156.83 | 156.83 | 186.02 | 211.45 | 141.06 | 143.9 | Upgrade
|
| Revenue | 11,570 | 11,665 | 11,595 | 13,232 | 12,431 | 10,876 | Upgrade
|
| Revenue Growth (YoY) | 0.31% | 0.60% | -12.38% | 6.44% | 14.29% | 7.78% | Upgrade
|
| Cost of Revenue | 7,742 | 7,827 | 7,208 | 7,971 | 7,759 | 6,469 | Upgrade
|
| Gross Profit | 3,828 | 3,838 | 4,387 | 5,261 | 4,672 | 4,407 | Upgrade
|
| Selling, General & Admin | 2,241 | 2,259 | 2,550 | 2,904 | 2,753 | 2,579 | Upgrade
|
| Research & Development | 387.89 | 375.32 | 419.14 | 385.24 | 329.47 | 324.35 | Upgrade
|
| Other Operating Expenses | 123.95 | 114.96 | 103.47 | 89.41 | 80.78 | 61.02 | Upgrade
|
| Operating Expenses | 2,779 | 2,770 | 3,080 | 3,386 | 3,188 | 2,929 | Upgrade
|
| Operating Income | 1,049 | 1,068 | 1,307 | 1,875 | 1,484 | 1,478 | Upgrade
|
| Interest Expense | -335.75 | -349.97 | -343.7 | -434.01 | -461.68 | -561.07 | Upgrade
|
| Interest & Investment Income | 72.31 | 69.66 | 92.75 | 529.44 | 380.87 | 323 | Upgrade
|
| Currency Exchange Gain (Loss) | 29.81 | 29.81 | 46.5 | 153.25 | -31.74 | -76.11 | Upgrade
|
| Other Non Operating Income (Expenses) | -22.33 | -32.98 | -43.03 | -42.16 | -55.59 | -87.77 | Upgrade
|
| EBT Excluding Unusual Items | 793.34 | 784.79 | 1,059 | 2,082 | 1,316 | 1,076 | Upgrade
|
| Impairment of Goodwill | -707.56 | -707.56 | -208.16 | -491.85 | -29.36 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -194.51 | -194.06 | 1.2 | -4.84 | 8.52 | 10.26 | Upgrade
|
| Gain (Loss) on Sale of Assets | 6.42 | 3.75 | 28.11 | -21.26 | -22.43 | 2.2 | Upgrade
|
| Asset Writedown | -108.53 | -108.59 | -88.96 | -31.51 | -93.3 | -24.15 | Upgrade
|
| Other Unusual Items | 76.4 | 61.16 | 101.04 | 90.16 | 101.87 | 100.44 | Upgrade
|
| Pretax Income | -134.44 | -160.51 | 892.39 | 1,623 | 1,281 | 1,165 | Upgrade
|
| Income Tax Expense | 181.78 | 182.09 | 215.46 | 495.49 | 361.04 | 270.08 | Upgrade
|
| Earnings From Continuing Operations | -316.22 | -342.59 | 676.93 | 1,127 | 920.2 | 895.01 | Upgrade
|
| Minority Interest in Earnings | 46.01 | 43.6 | -374.81 | -693.72 | -252.4 | -243.27 | Upgrade
|
| Net Income | -270.21 | -298.99 | 302.12 | 433.48 | 667.81 | 651.73 | Upgrade
|
| Net Income to Common | -270.21 | -298.99 | 302.12 | 433.48 | 667.81 | 651.73 | Upgrade
|
| Net Income Growth | - | - | -30.30% | -35.09% | 2.47% | 5.08% | Upgrade
|
| Shares Outstanding (Basic) | 1,973 | 1,975 | 1,980 | 1,980 | 1,980 | 1,975 | Upgrade
|
| Shares Outstanding (Diluted) | 1,973 | 1,975 | 1,980 | 1,980 | 1,980 | 1,975 | Upgrade
|
| Shares Change (YoY) | -0.32% | -0.25% | -0.02% | 0.02% | 0.25% | -1.29% | Upgrade
|
| EPS (Basic) | -0.14 | -0.15 | 0.15 | 0.22 | 0.34 | 0.33 | Upgrade
|
| EPS (Diluted) | -0.14 | -0.15 | 0.15 | 0.22 | 0.34 | 0.33 | Upgrade
|
| EPS Growth | - | - | -30.29% | -35.10% | 2.21% | 6.45% | Upgrade
|
| Free Cash Flow | 765.13 | 669.02 | 305.35 | 1,277 | 13.19 | 1,142 | Upgrade
|
| Free Cash Flow Per Share | 0.39 | 0.34 | 0.15 | 0.65 | 0.01 | 0.58 | Upgrade
|
| Dividend Per Share | - | - | 0.220 | 0.220 | 0.220 | 0.220 | Upgrade
|
| Gross Margin | 33.09% | 32.90% | 37.83% | 39.76% | 37.58% | 40.52% | Upgrade
|
| Operating Margin | 9.07% | 9.16% | 11.27% | 14.17% | 11.94% | 13.59% | Upgrade
|
| Profit Margin | -2.33% | -2.56% | 2.61% | 3.28% | 5.37% | 5.99% | Upgrade
|
| Free Cash Flow Margin | 6.61% | 5.73% | 2.63% | 9.65% | 0.11% | 10.50% | Upgrade
|
| EBITDA | 1,993 | 1,995 | 2,165 | 2,647 | 2,200 | 2,175 | Upgrade
|
| EBITDA Margin | 17.23% | 17.10% | 18.67% | 20.00% | 17.70% | 19.99% | Upgrade
|
| D&A For EBITDA | 943.96 | 926.8 | 858.19 | 771.15 | 716.37 | 696.31 | Upgrade
|
| EBIT | 1,049 | 1,068 | 1,307 | 1,875 | 1,484 | 1,478 | Upgrade
|
| EBIT Margin | 9.07% | 9.16% | 11.27% | 14.17% | 11.94% | 13.59% | Upgrade
|
| Effective Tax Rate | - | - | 24.14% | 30.54% | 28.18% | 23.18% | Upgrade
|
| Revenue as Reported | 11,570 | 11,665 | 11,595 | 13,232 | 12,431 | - | Upgrade
|
| Advertising Expenses | - | 410.08 | 610.81 | 758.7 | 887.58 | 979.61 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.